Author(s):
Prem Kumar, Reneesh Jaiswal, Rajesh Meshram, Sudhish Rai
Email(s):
yprem173@gmail.com
DOI:
10.52711/0974-4150.2026.00013 
Address:
Prem Kumar1*, Reneesh Jaiswal2, Rajesh Meshram3, Sudhish Rai4
1,2,3School of Pharmacy, Chouksey Engineering College Bilaspur, Chhattisgarh, India.
4Jagrani Devi Pharmacy College, Baradwar, Shakti, Chhattisgarh, India.
*Corresponding Author
Published In:
Volume - 19,
Issue - 1,
Year - 2026
ABSTRACT:
The relentless rise of antimicrobial resistance (AMR) poses a grave threat to global public health, necessitating the urgent discovery of novel therapeutic agents with new mechanisms of action. Nitrogen-containing heterocycles have long been recognized as privileged structures in drug discovery due to their diverse biological activities. Among them, the carbazole nucleus, a tricyclic aromatic system comprising two benzene rings fused on either side of a pyrrole ring, has emerged as a highly promising scaffold. Carbazole derivatives are widely distributed in nature and have demonstrated a broad spectrum of pharmacological properties, including significant antimicrobial activity. This review systematically consolidates and critically evaluates the recent advancements (from approximately 2015 to the present) in the design, synthesis, and antimicrobial evaluation of new carbazole-based derivatives. We delve into various synthetic strategies, ranging from classical methods like the Bischler-Napieralski and Graebe-Ullmann reactions to modern transition-metal-catalyzed approaches for constructing the carbazole core and its functionalized analogues. A major focus is placed on the structure-activity relationship (SAR) studies, elucidating how different substituents—such as halogens, nitro groups, amino groups, and various heterocyclic hybrids—influence the potency and spectrum of activity against a panel of pathogenic bacteria and fungi. The review also discusses the potential mechanisms of action, including DNA intercalation, inhibition of efflux pumps, and disruption of microbial cell membranes. Finally, we address the current challenges and future perspectives for developing carbazole derivatives as a new class of clinically viable antimicrobial agents to combat the escalating AMR crisis.
Cite this article:
Prem Kumar, Reneesh Jaiswal, Rajesh Meshram, Sudhish Rai. Carbazole: A Versatile Scaffold in Medicinal Chemistry – A Review on the Synthesis and Antimicrobial Evaluation of New Derivatives. Asian Journal of Research in Chemistry. 2026; 19(1):73-6. doi: 10.52711/0974-4150.2026.00013
Cite(Electronic):
Prem Kumar, Reneesh Jaiswal, Rajesh Meshram, Sudhish Rai. Carbazole: A Versatile Scaffold in Medicinal Chemistry – A Review on the Synthesis and Antimicrobial Evaluation of New Derivatives. Asian Journal of Research in Chemistry. 2026; 19(1):73-6. doi: 10.52711/0974-4150.2026.00013 Available on: https://ajrconline.org/AbstractView.aspx?PID=2026-19-1-13
REFERENCES:
1. World Health Organization. (2021). Global action plan on antimicrobial resistance. WHO.
2. Ventola, C. L. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and Therapeutics. 2015; 40(4): 277.
3. Knölker, H. J., and Reddy, K. R. Isolation and synthesis of biologically active carbazole alkaloids. Chemical Reviews. 2002; 102(11): 4303-4427.
4. Itoigawa, M., Kashiwada, Y., Ito, C., Furukawa, H., Tachibana, Y., and Bastow, K. F. Antitumor agents 203. Carbazole alkaloid murrayaquinone A and related synthetic carbazolequinones as cytotoxic agents. Journal of Natural Products. 2000; 63(7): 893-897.
5. Schmidt, A. W., Reddy, K. R., and Knölker, H. J. Occurrence, biogenesis, and synthesis of biologically active carbazole alkaloids. Chemical Reviews. 2012; 112(6): 3193-3328.
6. Graebe, C., and Ullmann, F. Ueber die Carbazolgruppe. Justus Liebigs Annalen der Chemie. 1896; 291(1): 1-13.
7. Bischler, A., and Napieralski, B. Zur Kenntniss einer neuen Isochinolinsynthese. Berichte der deutschen chemischen Gesellschaft. 1893; 26(2): 1903-1908.
8. Cadogan, J. I. G. (). A new synthesis of carbazoles and indoles. Journal of the Chemical Society. 1962; 4253-4257.
9. Wolfe, J. P., Wagaw, S., and Buchwald, S. L. An improved catalyst system for aromatic carbon–nitrogen bond formation: the possible involvement of bis(phosphine) complexes. Journal of the American Chemical Society. 1996; 118(33): 7914-7925.
10. Miyaura, N., and Suzuki, A. Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chemical Reviews. 1995; 95(7): 2457-2483.
11. Shapiro, N. D., and Toste, F. D. A reactivity-driven approach to the discovery and development of gold-catalyzed organic reactions. Synlett. 2007; 2007(16): 2479-2484.
12. Suman, K., Bishnoi, A., and Srivastava, S. S. Synthesis and antimicrobial evaluation of some novel carbazole derivatives. Journal of Heterocyclic Chemistry. 2019; 56(4): 1425-1433.
13. Patil, S. A., Wang, J., Li, X. S., and Chen, Z. Synthesis and biological evaluation of novel carbazole amin alcohols as potential antimicrobial agents. Bioorganic and Medicinal Chemistry Letters. 2012; 22(14): 4724-4727.
14. Zhang, L., Peng, X. M., Damu, G. L., Geng, R. X., and Zhou, C. H. Comprehensive review in current developments of imidazole-based medicinal chemistry. Medicinal Research Reviews. 2014; 34(2): 340-437. (For context on hybrids).
15. Chai, X., Zhang, J., Cao, Y., Zou, Y., Wu, Q., Zhang, D., ... and Zhou, Y. Design, synthesis and molecular docking of carbazole derivatives containing an aminoguanidine moiety as potent antibacterial agents. European Journal of Medicinal Chemistry. 2017; 143: 66-74.
16. Kini, S. G., and Choudhary, S. Synthesis, antimicrobial and antioxidant activities of some new carbazole-chalcone hybrids. Medicinal Chemistry Research. 2017; 26(8): 1681-1692.
17. Kumar, D., Kumar, N. M., Chang, K. H., and Shah, K. Synthesis and anticancer activity of 5, 11-dihydro-10H-dibenzo [b, e] [1, 4] diazepin-11-one and carbazole analogs. European Journal of Medicinal Chemistry. 2010; 45(10): 4664-4668.
18. Denny, W. A. Acridine derivatives as chemotherapeutic agents. Current Medicinal Chemistry. 2002; 9(18): 1655-1665.
19. Marques, M. R., Loebenberg, R., and Almukainzi, M. Simulated biological fluids with possible application in dissolution testing. Dissolution Technologies. 2011; 18(3): 15-28.
20. Stavri, M., Piddock, L. J., and Gibbons, S. Bacterial efflux pump inhibitors from natural sources. Journal of Antimicrobial Chemotherapy. 2007; 59(6): 1247-1260.